ACETO Corp (ACET) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
ACETO Reports Third Quarter Fiscal 2015 Results
May 7, 2015 5:00 PM EDTPORT WASHINGTON, N.Y., May 7, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the third quarter of fiscal 2015 ended March 31, 2015.
Third Quarter Fiscal 2015 versus Third Quarter Fiscal 2014
Net sales of $145.8 million versus $124.8 million, a 16.8% increase Gross profit of $36.6 million versus $25.0 million, a 46.6% increase Net income of $8.4 million versus $5.4 million, a 57.0% increase Diluted EPS of $0.29 versus $0.19, a 52.6% increase Non-GAAP Adjusted Net Income of $10.0 million versus $6.9 million, a... MoreACETO Reports Third Quarter Fiscal 2015 Results
May 7, 2015 5:00 PM EDTPORT WASHINGTON, N.Y., May 7, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the third quarter of fiscal 2015 ended March 31, 2015.
Third Quarter Fiscal 2015 versus Third Quarter Fiscal 2014
Net sales of $145.8 million versus $124.8 million, a 16.8% increase Gross profit of $36.6 million versus $25.0 million, a 46.6% increase Net income of $8.4 million versus $5.4 million, a 57.0% increase Diluted EPS of $0.29 versus $0.19, a 52.6% increase Non-GAAP Adjusted Net Income of $10.0 million versus $6.9 million, a... MoreACETO Board of Directors Declares Quarterly Cash Dividend
May 7, 2015 2:49 PM EDTPORT WASHINGTON, N.Y., May 7, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common share. This quarterly cash dividend will be distributed on June 25, 2015 to shareholders of record as of June 11, 2015.
ABOUT ACETO
ACETO Corporation, incorporated in 1947, is a global... More
ACETO Board of Directors Declares Quarterly Cash Dividend
May 7, 2015 2:49 PM EDTPORT WASHINGTON, N.Y., May 7, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common share. This quarterly cash dividend will be distributed on June 25, 2015 to shareholders of record as of June 11, 2015.
ABOUT ACETO
ACETO Corporation, incorporated in 1947, is a global... More
